Skip to main content
Clinical Trials/NCT02203747
NCT02203747
Completed
Not Applicable

Patient Perception of Visual Distortions

Abbott Medical Optics1 site in 1 country79 target enrollmentAugust 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cataract
Sponsor
Abbott Medical Optics
Enrollment
79
Locations
1
Primary Endpoint
Visual Distortion Symptoms
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to evaluate visual distortions reported by pseudophakic patients.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
January 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Corneal astigmatism of at least 0.75 diopters
  • Bilaterally-implanted with monofocal toric intraocular lenses in both eyes or with monofocal non-toric intraocular lenses in both eyes
  • At least one month postoperative from second-eye surgery
  • Ability to understand, read and write English to give consent and complete study questionnaire
  • Availability, willingness, and sufficient cognitive awareness to comply with examination procedures and study visits
  • Sign informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
  • Other protocol-defined inclusion criteria may apply

Exclusion Criteria

  • Any ocular pathology of clinical significance, as determined by the investigator, other than regular corneal astigmatism, that may affect visual outcomes or influence subjective ocular visual symptoms
  • Patient is pregnant or is lactating
  • Participation in any other clinical trial during the last 30 days prior to study enrollment or concurrent participation in any other ongoing clinical trial
  • Other protocol-defined exclusion criteria may apply

Outcomes

Primary Outcomes

Visual Distortion Symptoms

Time Frame: 1 week

Subjective rating of visual distortion symptoms under overall conditions at baseline. Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome. The minimum score was 0 and the maximum score was 3.

Study Sites (1)

Loading locations...

Similar Trials